Articles by January, 2025

The Chief Military Defense Attorney’s Office has confirmed a significant increase in the number of defense attorneys providing legal advice to soldiers and reservists regarding investigations related to the ongoing war. This surge in consultations is linked to multiple investigation mechanisms that have been put in place since the conflict began, including internal military probes and external audits

General Joseph Awan’s election as Lebanon’s new president marks a significant turning point for the country, ending a political deadlock that had lasted more than two years. His rise to power, supported by the United States, Saudi Arabia, and several Arab countries, is expected to prompt increased pressure on Israel to withdraw its forces from southern Lebanon by the end of January, as stipulated in a ceasefire agreement

Prime Minister Benjamin Netanyahu issued a statement to the Israeli public on Saturday evening, explaining the recent cabinet approval for the hostage release deal. The statement came following a government meeting that reviewed the details of the deal, which has faced both support and opposition from within the coalition

A stabbing attack took place this evening (Tuesday) in the bustling Nahalat Binyamin area of Tel Aviv, leaving four people injured. According to initial reports, a terrorist pulled out a knife and began attacking passersby in two separate locations within proximity. The victims included a 28-year-old man and a 24-year-old man, both of whom were in moderate condition, and two others, aged 24 and 59, who sustained lighter injuries. Emergency medical teams quickly arrived and transported the injured to nearby hospitals

The recent ceasefire in the Gaza Strip, along with the ongoing release of abducted Israeli citizens, marks a pivotal moment in Israel’s recovery following the October 7 attack. On Tuesday, IDF Chief of Staff Herzi Halevi and Southern Command Colonel Yaron Finkelman announced their resignations, signaling the end of their service in the Israeli Defense Forces (IDF)

Teva Pharmaceutical Industries has announced impressive results for its most promising innovative drug, Duvakitug, in treating colitis and Crohn's disease. The company revealed today that the drug achieved significantly better-than-expected outcomes in the second phase of clinical trials, outperforming a placebo in key efficacy measures. As a result, Teva's stock surged more than 15% in pre-market trading on the New York Stock Exchange